Jump to ContentJump to Main Navigation
Promising GenomicsIceland and deCODE Genetics in a World of Speculation$
Users without a subscription are not able to see the full content.

Michael Fortun and Roberto Reis

Print publication date: 2008

Print ISBN-13: 9780520247505

Published to California Scholarship Online: March 2012

DOI: 10.1525/california/9780520247505.001.0001

Show Summary Details
Page of

PRINTED FROM CALIFORNIA SCHOLARSHIP ONLINE (www.california.universitypressscholarship.com). (c) Copyright University of California Press, 2022. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in CALSO for personal use.date: 25 June 2022

PromiseXDisclosure

PromiseXDisclosure

Chapter:
(p.196) Ch 16 PromiseXDisclosure
Source:
Promising Genomics
Author(s):

Mike Fortun

Publisher:
University of California Press
DOI:10.1525/california/9780520247505.003.0017

The many stories about genomics which increasingly appear on television, in newspapers and magazines, and on the Internet reinforce the standard story that this is an industry based on “genetic information.” Genetic information, it is said, will provide a foundation for new drugs, new diagnostic kits, and new forms of therapy. But to the extent that the genomic industry is “based” on anything, it would be more accurate to say that it is based on the promise of genetic information—based on what genetic information may become in an anticipated, contingent, and open future. This begins to account for why the value of companies such as Celera Genomics, Millennium Pharmaceuticals, Incyte Genomics, and deCODE Genetics are “story stocks,” dependent not only on genetic technologies but on that other set of technologies for simultaneously producing and evaluating anticipated, contingent futures: literary technologies. Genomic companies, like their dot-com cousins that also emerged in the speculative economy of the 1990s, operated in the discursive space of the Private Securities Litigation Reform Act of 1995. The U.S. Securities and Exchange Commission makes disclosure necessary.

Keywords:   Private Securities Litigation, Securities and Exchange, disclosure, promise, genomics, genetic information, deCODE Genetics, story stocks, literary technologies, genomic companies

California Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.